Boston Strategics Corporation Announces Name To Strategia Therapeutics, Inc.
BOSTON--(BUSINESS WIRE)--Boston Strategic Corporation, an innovative pharmaceutical R&D company that specializes in streamlining the drug development processes, today announced its new name: Strategia Therapeutics, Inc., effective immediately.
The change, which comes on the Boston-based company’s third anniversary, more accurately reflects its emphasis on serving patients in need, says President and CEO Keizo Koya, Ph.D. “Strategia’s vision is to change the existing drug research and development paradigm,” Koya says. By creating a nimble approach to drug development, he notes, the company can reduce overall costs and time to market, thereby making new, affordable drugs available to patients whose medical needs would otherwise be unmet.
Help employers find you! Check out all the jobs and post your resume.
The change, which comes on the Boston-based company’s third anniversary, more accurately reflects its emphasis on serving patients in need, says President and CEO Keizo Koya, Ph.D. “Strategia’s vision is to change the existing drug research and development paradigm,” Koya says. By creating a nimble approach to drug development, he notes, the company can reduce overall costs and time to market, thereby making new, affordable drugs available to patients whose medical needs would otherwise be unmet.
Help employers find you! Check out all the jobs and post your resume.